A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies
|
|||||
|
       
  |
A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems. . . . → Read More: Lightweight AI Chip Designer Raises $2.8M in Seed Funds 
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches 
A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway 
News of those trials fueled healthy share price rises for the biotechnology companies developing the vaccines, shown in this weekend’s infographic. . . . → Read More: Infographic – Vaccines Boost Biotech Shares 
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal 
A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M 
A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round. . . . → Read More: Gene-Editing Enzyme Start-Up Gains $65M  Comments are closed  Finance  biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, university, venture capital 
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds. . . . → Read More: Coronavirus Antibody Maker Raises $80M in New Funds Comments are closed Finance, New products biomedical, biotechnology, Covid-19, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk. . . . → Read More: Oral Drug Delivery Company Acquired in $1.8B Deal Comments are closed Finance biomedical, biotechnology, chemistry, equity, Europe, investment, licensing, life sciences, merger, pharmaceuticals, physical sciences |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||